Alzheimer's Disease; Many Voices, One Message: research.(OPED)

The Washington Times (Washington, DC), November 15, 2002 | Go to article overview

Alzheimer's Disease; Many Voices, One Message: research.(OPED)


Byline: Dennis C. Revell, SPECIAL TO THE WASHINGTON TIMES

"That's the worst part of this disease. There's nobody to exchange memories with." (Nancy Reagan, Sept. 25, "60 Minutes II.")

Alzheimer's disease doesn't make special arrangements for anyone, even for the leader of the free world. In tragic irony, 20 years ago this week President Ronald Reagan launched a national campaign against Alzheimer's disease. In a historic White House ceremony, he drew national attention to Alzheimer's and defined it as a major health menace. He proclaimed November National Alzheimer's Disease Awareness Month, warning the American people of "the emotional, financial and social consequences of Alzheimer's disease." With vision and leadership, he argued for research as "the only hope for victims and families."

The brain is a miracle when it works, and a mystery when it fails. One of the most haunting, puzzling, and soon to be most costly of the brain's failures is Alzheimer's - a degenerative, progressive, and terminal brain disorder.

Most people think of Alzheimer's strictly as memory loss. It is much more, although memory loss alone would be scary enough. Memories are the records of our lives - the essential stuff of our identities and personalities - the very essence of what we share with those we love.

On Nov. 5, 1994, Ronald Reagan wrote a courageous letter to the American people about his own diagnosis of Alzheimer's, and his 1982 presidential campaign against the disease became his family's personal struggle.

We have made giant strides toward fulfilling his vision, and now this Congress and President Bush have the opportunity to finish the battle he began. Congress has steadily invested public funds in Alzheimer's research over the past 20 years and the Alzheimer's Association has added millions in private funds.

That investment in research is now paying off. Science is at the point where effective treatment and prevention of Alzheimer's is within reach. The research infrastructure is in place; the paths for further investigation are clear. The missing ingredient is money. A $1 billion federal investment now will pay big dividends in the future.

When Ronald Reagan sounded his battle cry against Alzheimer's, an estimated 2 million people were suffering from this awful disease. Today, the number has grown to more than 4 million, with an additional 19 million family members suffering the emotional and financial impact - 24 hours a day, seven days a week, 365 days a year.

Unfortunately, over the next 50 years, as many as 14 million baby boomers will be the next large pool of victims, unless we find ways to further slow down or stop the changes in their brains that might already be taking place.

The threat to so many American families should be enough to urge us to action, but the economic impact of the disease drives us as well. In just 10 years, the annual cost of Alzheimer's disease to Medicare and Medicaid will rise from $50 billion to more than $82 billion. …

The rest of this article is only available to active members of Questia

Sign up now for a free, 1-day trial and receive full access to:

  • Questia's entire collection
  • Automatic bibliography creation
  • More helpful research tools like notes, citations, and highlights
  • Ad-free environment

Already a member? Log in now.

Notes for this article

Add a new note
If you are trying to select text to create highlights or citations, remember that you must now click or tap on the first word, and then click or tap on the last word.
One moment ...
Default project is now your active project.
Project items

Items saved from this article

This article has been saved
Highlights (0)
Some of your highlights are legacy items.

Highlights saved before July 30, 2012 will not be displayed on their respective source pages.

You can easily re-create the highlights by opening the book page or article, selecting the text, and clicking “Highlight.”

Citations (0)
Some of your citations are legacy items.

Any citation created before July 30, 2012 will labeled as a “Cited page.” New citations will be saved as cited passages, pages or articles.

We also added the ability to view new citations from your projects or the book or article where you created them.

Notes (0)
Bookmarks (0)

You have no saved items from this article

Project items include:
  • Saved book/article
  • Highlights
  • Quotes/citations
  • Notes
  • Bookmarks
Notes
Cite this article

Cited article

Style
Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

(Einhorn, 1992, p. 25)

(Einhorn 25)

1

1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

Cited article

Alzheimer's Disease; Many Voices, One Message: research.(OPED)
Settings

Settings

Typeface
Text size Smaller Larger Reset View mode
Search within

Search within this article

Look up

Look up a word

  • Dictionary
  • Thesaurus
Please submit a word or phrase above.
Print this page

Print this page

Why can't I print more than one page at a time?

Full screen

matching results for page

Cited passage

Style
Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

"Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn, 1992, p. 25).

"Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn 25)

"Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences."1

1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

Cited passage

Thanks for trying Questia!

Please continue trying out our research tools, but please note, full functionality is available only to our active members.

Your work will be lost once you leave this Web page.

For full access in an ad-free environment, sign up now for a FREE, 1-day trial.

Already a member? Log in now.